Paul Larson

9.8k citations

153 papers · 5.8k indexed · 1 hit paper · h-index 40

Impact in

Neurology top 0.2%
- Neurological disorders and treatments
- Parkinson's Disease Mechanisms and Treatments
- Botulinum Toxin and Related Neurological Disorders
Cellular and Molecular Neuroscience top 0.5%
- Genetic Neurodegenerative Diseases
- Neuroscience and Neural Engineering
- Nerve injury and regeneration

Papers in ⓘ

Neurology 84
- Neurological disorders and treatments 77
- Parkinson's Disease Mechanisms and Treatments 40
- Transcranial Magnetic Stimulation Studies 14
- Botulinum Toxin and Related Neurological Disorders 12
Cellular and Molecular Neuroscience 48
- Nerve injury and regeneration 17
- Genetic Neurodegenerative Diseases 17
- Neuroscience and Neural Engineering 11

Co-authors: Philip A. Starr (51 shared papers)Alastair J. Martin (27 shared papers)Jill L. Ostrem (24 shared papers)Krystof S. Bankiewicz (17 shared papers)Chadwick W. Christine (12 shared papers)H. B. Haag (17 shared papers)Michael J. Aminoff (4 shared papers)Steven W. Cheung (7 shared papers)
Journals: Journal of neurosurgery (11 papers)Toxicology and Applied Pharmacology (11 papers)Stereotactic and Functional Neurosurgery (10 papers)Neurosurgery (10 papers)Parkinsonism & Related Disorders (8 papers)
Partner nations: United States France United Kingdom

In The Last Decade

Paul Larson

149 papers receiving 5.6k citations

Hit Papers

align trajectories log scale

Long-term wireless streaming of neural recordings for circuit discovery and adaptive stimulation in individuals with Parkinson’s disease 2021 · 192 citations

Peers

Countries citing papers authored by Paul Larson

Since Specialization

Citations

This map shows the geographic impact of Paul Larson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Larson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Larson more than expected).

Fields of papers citing papers by Paul Larson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Larson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Larson. The network helps show where Paul Larson may publish in the future.

Co-authors

The 25 scholars most cited alongside Paul Larson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul Larson Line = papers co-authored together Paul Larson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 153 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial The Lancet Neurology ·William J. Marks, Jill L. Ostrem, L. Verhagen, Philip A. Starr, Paul Larson, Roy A.E. Bakay, R. L. Taylor, Deborah A. Cahn‐Weiner, A. Jon Stoessl, C. Warren Olanow, Raymond T. Bartus	2008	441
2	Safety and tolerability of putaminal AADC gene therapy for Parkinson disease Neurology ·Chadwick W. Christine, Philip A. Starr, Paul Larson, Jamie L. Eberling, William J. Jagust, Richard A. Hawkins, Henry F. VanBrocklin, Joan Wright, Krystof S. Bankiewicz, Michael J. Aminoff	2009	323
3	Results from a phase I safety trial of hAADC gene therapy for Parkinson disease Neurology ·Jamie L. Eberling, William J. Jagust, Chadwick W. Christine, Phillip A. Starr, Paul Larson, Krystof S. Bankiewicz, Michael J. Aminoff	2008	284
4	Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease Human Gene Therapy ·Gabriele Mittermeyer, Chadwick W. Christine, Kathryn H. Rosenbluth, Suzanne L. Baker, Philip A. Starr, Paul Larson, Paul L. Kaplan, John Forsayeth, Michael J. Aminoff, Krystof S. Bankiewicz	2012	208
5	Long-term wireless streaming of neural recordings for circuit discovery and adaptive stimulation in individuals with Parkinson’s disease Nature Biotechnology ·Ro’ee Gilron, Simon Little, Randy Perrone, Robert Wilt, Coralie de Hemptinne, Maria S. Yaroshinsky, Caroline A. Racine, Sarah S. Wang, Jill L. Ostrem, Paul Larson, Doris D. Wang, Nick B. Galifianakis, Ian O. Bledsoe, Marta San Luciano, Heather E. Dawes, Gregory A. Worrell, Václav Křemen, David A. Borton, Timothy Denison, Philip A. Starr Hit paper breakdown →	2021	192
6	Subthalamic nucleus deep brain stimulator placement using high-field interventional magnetic resonance imaging and a skull-mounted aiming device: technique and application accuracy Journal of neurosurgery ·Philip A. Starr, Alastair J. Martin, Jill L. Ostrem, Pekka Talke, Nadja Levesque, Paul Larson	2009	189
7	DEEP BRAIN STIMULATOR HARDWARE-RELATED INFECTIONS Neurosurgery ·Karl Sillay, Paul Larson, Philip A. Starr	2008	174
8	Thalamic Deep Brain Stimulation for Essential Tremor: Relation of Lead Location to Outcome Neurosurgery ·Efstathios Papavassiliou, Geoff Rau, Susan Heath, Aviva Abosch, Nicholas M. Barbaro, Paul Larson, Kathleen R. Lamborn, Philip A. Starr	2004	173
9	Prefrontal-Subthalamic Hyperdirect Pathway Modulates Movement Inhibition in Humans Neuron ·Witney Chen, Coralie de Hemptinne, Andrew M. Miller, Michael Leibbrand, Simon Little, Daniel A. Lim, Paul Larson, Philip A. Starr	2020	156
10	Traumatic intracranial aneurysms Neurosurgical FOCUS ·Paul Larson, Andrew Reisner, Dante J. Morassutti, Bassam Abdulhadi, John E. Harpring	2000	152
11	TOBACCO The American Journal of the Medical Sciences ·Paul Larson, H. B. Haag, H. Silvette	1961	142
12	Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson’s disease Journal of neurosurgery ·Jill L. Ostrem, Nathan Ziman, Nicholas B. Galifianakis, Philip A. Starr, Marta San Luciano, Maya Katz, Caroline A. Racine, Alastair J. Martin, Leslie C. Markun, Paul Larson	2015	117
13	Magnetic resonance imaging–guided phase 1 trial of putaminal AADC gene therapy for Parkinson's disease Annals of Neurology ·Chadwick W. Christine, Krystof S. Bankiewicz, Amber D. Van Laar, R. Mark Richardson, Bernard Ravina, Adrian P. Kells, Brendon Boot, Alastair J. Martin, John G. Nutt, Marin E. Thompson, Paul Larson	2019	116
14	THE ACTIONS OF NICOTINE ON CENTRAL NERVOUS SYSTEM FUNCTIONS Pharmacological Reviews ·H. Silvette, Ebbe Curtis Hoff, Paul Larson, H. B. Haag	1962	115
15	An Optimized System for Interventional Magnetic Resonance Imaging-Guided Stereotactic Surgery Operative Neurosurgery ·Paul Larson, Philip A. Starr, Geoffrey Bates, Lisa Tansey, R. Mark Richardson, Alastair J. Martin	2011	107
16	Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's Disease Molecular Therapy ·R. Mark Richardson, Adrian P. Kells, Kathryn H. Rosenbluth, Ernesto A. Salegio, Massimo S. Fiandaca, Paul Larson, Philip A. Starr, Alastair J. Martin, Russell R. Lonser, Howard J. Federoff, John Forsayeth, Krystof S. Bankiewicz	2011	106
17	An unexpectedly high rate of revisions and removals in deep brain stimulation surgery: Analysis of multiple databases Parkinsonism & Related Disorders ·John D. Rolston, Dario J. Englot, Philip A. Starr, Paul Larson	2016	103
18	Tinnitus modulation by deep brain stimulation in locus of caudate neurons (area LC) Neuroscience ·Steven W. Cheung, Paul Larson	2010	87
19	Frameless Stereotactic Neurosurgery Using Intraoperative Magnetic Resonance Imaging: Stereotactic Brain Biopsy Neurosurgery ·Thomas M. Moriarty, Alfredo Quiñones‐Hinojosa, Paul Larson, Eben Alexander, Phillip Gleason, Richard B. Schwartz, Ferenc A. Jólesz, Peter McL. Black	2000	85
20	Magnetic Resonance Imaging of Implanted Deep Brain Stimulators: Experience in a Large Series Stereotactic and Functional Neurosurgery ·Paul Larson, R. Mark Richardson, Philip A. Starr, Alastair J. Martin	2007	84

About Paul Larson

Paul Larson is a scholar working on Neurology, Cellular and Molecular Neuroscience, Neurology, Sensory Systems and Radiology, Nuclear Medicine and Imaging, having authored 153 papers that have together received 5.8k indexed citations. Recurring topics across this work include Neurological disorders and treatments (77 papers), Parkinson's Disease Mechanisms and Treatments (40 papers), Nerve injury and regeneration (17 papers), Genetic Neurodegenerative Diseases (17 papers), Transcranial Magnetic Stimulation Studies (14 papers), Advanced MRI Techniques and Applications (13 papers), Botulinum Toxin and Related Neurological Disorders (12 papers) and Neuroscience and Neural Engineering (11 papers). The work is most often cited by research in Neurology (3.1k citations), Cellular and Molecular Neuroscience (2.3k citations), Neurology (587 citations), Sensory Systems (208 citations) and Cognitive Neuroscience (813 citations). Paul Larson has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Philip A. Starr, Alastair J. Martin, Jill L. Ostrem, Krystof S. Bankiewicz, Chadwick W. Christine, H. B. Haag, Michael J. Aminoff, Steven W. Cheung, H. Silvette and R. Mark Richardson. Their work appears in journals such as Journal of neurosurgery, Toxicology and Applied Pharmacology, Stereotactic and Functional Neurosurgery, Neurosurgery and Parkinsonism & Related Disorders.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact